04:41 PM EDT, 07/23/2024 (MT Newswires) -- Nicole LaBrosse, Senior Vice President, CFO, on July 22, 2024, sold 5,000 shares in Halozyme Therapeutics ( HALO ) for $269,662. Following the Form 4 filing with the SEC, LaBrosse has control over a total of 15,480 shares of the company, with 15,480 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588924019936/xslF345X03/form4-07232024_080706.xml

Price: 55.20, Change: -0.20, Percent Change: -0.36